Patent · US Expired

Androgen derivatives and uses thereof

US6630453B1 · kind B1 · utility

0Cited by
160References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2000
Grant dateOct 7, 2003
Priority date—
Expiry dateMay 4, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J71/0047
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Androgen glycosides provide free, circulatory androgen on oral administration as they are subject to less, first pass breakdown by the liver.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.